Using CAR-T Cell Therapy to Revolutionize Cancer Treatment

Using CAR-T Cell Therapy to Revolutionize Cancer Treatment
A state-of-the-art development in cancer immunotherapy is chimeric antigen receptor (T-cell) CAR-T Cell Therapy treatment. This treatment uses the immune system's built-in defenses to provide precision cancer treatment by genetically altering a patient's T cells to target and kill cancer cells. With an emphasis on hematologic cancers and the new possibilities in solid tumors, this study describes the operational applications, strategic advantages, dangers, and tactical directions for utilizing CAR-T Cell Therapy to transform the treatment of malignancies.